Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications
Article in Expert Review of Clinical Immunology (June 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Response of a Novel KANK1::ALK Fusion to Alectinib in an Advanced Lung Adenocarcinoma: A Case Report.
Article in Journal of the National Comprehensive Cancer Network (February 2024)
Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions
Article in Biomedicines (January 2024)